Former Red Bull Canada and Juul Labs Canada executive, Nicholas Kadysh, has been appointed to the role of Executive Special Advisor by Clearmind Medicine.
Awakn Life Sciences has announced that it has signed a five-year lease to open Awakn Clinics Trondheim.
Psyrise, a mental health marketing company located in South Florida, has released a first-of-its-kind marketing platform for health practitioners in the field of psychedelic therapies.
Biopharmaceutical company, Ceruvia Lifesciences, has announced the appointment of Stephen Hurst and David Steinberg to its Board of Directors, effective immediately.
APPA is aiming to integrate psychedelics into the US healthcare system and ensure safe access for all who can benefit from the treatments.
University of Cincinnati postdoctoral researcher Neşe Devenot has stated that the field of psychedelics is fraught with ethical concerns and financial interests.
Optimi Health has received approval from Health Canada to manufacture and distribute psychedelic medicines.
InsightAce Analytic has projected that the global psychedelic therapeutics market, valued at US$3.61bn in 2021, is expected to reach US$8.31bn (~£6.92bn) by 2028.
World renowned auction house Christie’s partnered with the Multidisciplinary Association for Psychedelic Studies (MAPS) and leading artists to raise funds that will be donated to MAPS to support the...
Clerkenwell Health is expanding its pan-European advisory board with the addition of Dr David Erritzoe, Dr Dea Siggaard Stenbæk, Dr Kim Kuypers and Dr James Stone...
